New therapeutic avenues in autoimmunity
- 31 December 1996
- journal article
- review article
- Published by Elsevier in Research in Immunology
- Vol. 147 (6) , 361-376
- https://doi.org/10.1016/0923-2494(96)82045-1
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Long-term anti-CD4 treatment of MRL/Ipr mice ameliorates immunopathology and lymphoproliferation but fails to suppress rheumatoid factor productionClinical Immunology and Immunopathology, 1991
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- Prevention of diabetes in BB/Wor rats treated with monoclonal antibodies to interferon-γThe Lancet, 1990
- Monoclonal antibodies and arthritisInflammation Research, 1990
- Immunomodulating therapy of rheumatoid arthritis by high-dose intravenous immunoglobulinJournal of Molecular Medicine, 1989
- Intravenous treatment with γ-globulin of autoimmune neutropenia of infancyThe Journal of Pediatrics, 1988
- Treatment of Antibody-Mediated Pure Red-Cell Aplasia with High-Dose Intravenous Gamma GlobulinNew England Journal of Medicine, 1987
- High-dose IVIgG in autoimmune hemolytic anemiaThe Journal of Pediatrics, 1986
- Effect of intravenous immune globulin on natural killer cell activity: Possible association with autoimmune neutropenia and idiopathic thrombocytopeniaThe Journal of Pediatrics, 1986
- Effect of Dietary Enrichment with Eicosapentaenoic and Docosahexaenoic Acids on in Vitro Neutrophil and Monocyte Leukotriene Generation and Neutrophil FunctionNew England Journal of Medicine, 1985